Integral Investment Advisors’s AbbVie ABBV Stock Holding History

Integral Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$389K	Buy	1,545 +91	+6%	+$19.6K	0.09%	129
2026 Q1	$316K	Sell	1,454 -1,019	-41%	-$226K	0.08%	138
2025 Q4	$565K	Buy	2,473 +846	+52%	+$193K	0.14%	98
2025 Q3	$377K	Sell	1,627 -154	-9%	-$31.4K	0.1%	112
2025 Q2	$331K	Sell	1,781 -50	-3%	-$9.29K	0.09%	128
2025 Q1	$384K	Buy	1,831 +2	+0.1%	+$389	0.12%	113
2024 Q4	$325K	Sell	1,829 -109	-6%	-$20K	0.11%	122
2024 Q3	$383K	Buy	1,938 +243	+14%	+$45.4K	0.13%	113
2024 Q2	$286K	Sell	1,695 -107	-6%	-$17.7K	0.11%	121
2024 Q1	$325K	Buy	+1,802	New	+$311K	0.13%	113
2022 Q2	–	Sell	-1,581	Closed	-$256K	–	79
2022 Q1	$256K	Buy	+1,581	New	+$230K	0.16%	83

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Integral Investment Advisors's ABBV Position: Q2 2026 in Review

Integral Investment Advisors increased its AbbVie (ABBV) stake by 6.3% in Q2 2026, buying an estimated $19.6K and bringing the position to 1,545 shares worth $389K. The position accounts for 0.09% of the portfolio, ranked #129.

Integral Investment Advisors first reported a position in ABBV in Q1 2022 and has held it in 11 quarters since. The position peaked at $565K in Q4 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Integral Investment Advisors held 1,545 shares of AbbVie worth $389K as of Q2 2026.
Integral Investment Advisors bought 91 AbbVie shares in Q2 2026, an estimated $19.6K.
AbbVie made up 0.09% of Integral Investment Advisors's portfolio in Q2 2026, its #129 holding.
Integral Investment Advisors first reported a position in AbbVie in Q1 2022 and has held it in 11 quarters since.
Integral Investment Advisors's AbbVie position peaked at $565K in Q4 2025.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Integral Investment Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.